J&J Fights For Judgment In Drug Pricing Suit

Law360, New York (August 21, 2007, 12:00 AM EDT) -- Johnson & Johnson has rejected a bid by plaintiffs in the massive antitrust class action over the alleged artificial inflation of the prices of various prescription medications to decide whether to grant treble damages and attorneys' fees before entering a final judgment, arguing that it is “entitled to finality.”

The company said in court documents filed Monday in the U.S. District Court for the District of Massachusetts that it has already been vindicated by U.S. District Judge Patti B. Saris' June 21 ruling which found that...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.